|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A01N 63/00 | |
| C12N 9/16 | |||
| C12N 15/00 | |||
| C07H 21/04 |
| (11) | Patento numeris | 2975942 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14770870.5 |
| Europos patento paraiškos padavimo data | 2014-03-20 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-01-27 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-08-08 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2014/031360 |
| Data | 2014-03-20 |
| (87) | Numeris | WO 2014/153470 |
| Data | 2014-09-25 |
| (30) | Numeris | Data | Šalis |
| 201361804076 P | 2013-03-21 | US |
| (72) |
GREGORY, Philip D., US
HOLMES, Michael C., US
PASCHON, David, US
ZHANG, Lei, US
BONINI, Maria Chiara, IT
GENOVESE, Pietro, IT
MAGNANI, Zulma, IT
MASTAGLIO, Sara, IT
NALDINI, Luigi, IT
|
| (73) |
Ospedale San Raffaele S.r.l.,
Via Olgettina 60, 20132 Milano,
IT
Sangamo Therapeutics, Inc., 501 Canal Blvd. Suite A100, Richmond, CA 94804, US |
| (54) | TARGETED DISRUPTION OF T CELL RECEPTOR GENES USING ENGINEERED ZINC FINGER PROTEIN NUCLEASES |
| TARGETED DISRUPTION OF T CELL RECEPTOR GENES USING ENGINEERED ZINC FINGER PROTEIN NUCLEASES |